• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Evidence-based therapy for type 2 diabetes. The best and worst of times.

作者信息

Flemmer M C, Vinik A I

机构信息

Department of Internal Medicine, Eastern Virginia Medical School of the Medical College, Norfolk 23510, USA.

出版信息

Postgrad Med. 2000 May 1;107(5):27-8, 31-4, 37-40, passim. doi: 10.3810/pgm.2000.5.1.1064.

DOI:10.3810/pgm.2000.5.1.1064
PMID:10844940
Abstract

Type 2 diabetes, which is increasing in prevalence, is a multifaceted disease that presents a challenge to the primary care physician. In this article, Drs Flemmer and Vinik review the significant findings of several important clinical trials and present a method of comprehensive staged management to improve the quality of patient care.

摘要

相似文献

1
Evidence-based therapy for type 2 diabetes. The best and worst of times.2型糖尿病的循证治疗。最好与最坏的时代。
Postgrad Med. 2000 May 1;107(5):27-8, 31-4, 37-40, passim. doi: 10.3810/pgm.2000.5.1.1064.
2
Implications of the UKPDS Study for general practice care of type 2 diabetes.英国前瞻性糖尿病研究对2型糖尿病全科护理的启示。
Br J Gen Pract. 1999 Dec;49(449):1009.
3
Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients.维格列汀与格列美脲对2型糖尿病患者餐后血脂异常及胰岛素抵抗的影响比较。
Metabolism. 2014 Jul;63(7):957-67. doi: 10.1016/j.metabol.2014.04.008. Epub 2014 Apr 23.
4
Requirement for hypertension and hyperlipidemia medication in U.S. and Japanese patients with diabetes.美国和日本糖尿病患者对高血压和高脂血症药物的需求。
Am J Med. 2004 Nov 1;117(9):711-2. doi: 10.1016/j.amjmed.2004.06.030.
5
Effects of combined therapy with glipizide and Aralia root bark extract on glycemic control and lipid profiles in patients with type 2 diabetes mellitus.格列吡嗪与龙牙楤木根皮提取物联合治疗对2型糖尿病患者血糖控制及血脂水平的影响。
J Sci Food Agric. 2015 Mar 15;95(4):739-44. doi: 10.1002/jsfa.6829. Epub 2014 Aug 22.
6
The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with type 2 diabetes.维格列汀治疗对2型糖尿病患者致动脉粥样硬化餐后残余颗粒及低密度脂蛋白颗粒大小的影响。
Diabet Med. 2013 Jun;30(6):756-7. doi: 10.1111/dme.12094.
7
[Prevention of microalbuminuria in type 2 diabetes. BENEDICT study].[2型糖尿病中微量白蛋白尿的预防。本尼迪克特研究]
Internist (Berl). 2006 Feb;47(2):199-200; discussion 200. doi: 10.1007/s00108-005-1560-0.
8
Lipid lowering with dietary supplements: focus on diabetes.用膳食补充剂降脂:关注糖尿病。
Maturitas. 2012 Jun;72(2):113-6. doi: 10.1016/j.maturitas.2012.03.001. Epub 2012 Mar 28.
9
Lipid lowering drugs in diabetes: absolute risk reduction is what counts.糖尿病中的降脂药物:绝对风险降低才是关键。
BMJ. 2006 May 27;332(7552):1272. doi: 10.1136/bmj.332.7552.1272-a.
10
A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care.加拿大初级保健中 2 型糖尿病与非 2 型糖尿病患者的心血代谢风险评估和管理比较。
Diabetes Obes Metab. 2013 Dec;15(12):1093-100. doi: 10.1111/dom.12134. Epub 2013 Jun 11.

引用本文的文献

1
Pioglitazone: a review of its use in type 2 diabetes mellitus.吡格列酮:其在2型糖尿病治疗中应用的综述
Drugs. 2006;66(1):85-109. doi: 10.2165/00003495-200666010-00005.